PH12013501951A1 - Agent for improving or maintaining qol - Google Patents

Agent for improving or maintaining qol

Info

Publication number
PH12013501951A1
PH12013501951A1 PH1/2013/501951A PH12013501951A PH12013501951A1 PH 12013501951 A1 PH12013501951 A1 PH 12013501951A1 PH 12013501951 A PH12013501951 A PH 12013501951A PH 12013501951 A1 PH12013501951 A1 PH 12013501951A1
Authority
PH
Philippines
Prior art keywords
agent
improving
maintaining
fatigue
qol
Prior art date
Application number
PH1/2013/501951A
Other languages
English (en)
Inventor
Noriyuki Kouda
Takao Saito
Shoji Shinkai
Masamichi Toba
Mina Tsubouchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PH12013501951A1 publication Critical patent/PH12013501951A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
PH1/2013/501951A 2011-03-31 2012-03-28 Agent for improving or maintaining qol PH12013501951A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011080814 2011-03-31
PCT/JP2012/058145 WO2012133533A1 (ja) 2011-03-31 2012-03-28 Ｑｏｌ改善又は持続剤

Publications (1)

Publication Number Publication Date
PH12013501951A1 true PH12013501951A1 (en) 2019-07-03

Family

ID=46931242

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/501951A PH12013501951A1 (en) 2011-03-31 2012-03-28 Agent for improving or maintaining qol

Country Status (12)

Country Link
US (2) US9623054B2 (enExample)
EP (1) EP2692349B1 (enExample)
JP (2) JP6061842B2 (enExample)
KR (1) KR101878525B1 (enExample)
CN (1) CN103458905A (enExample)
AU (1) AU2012233590B2 (enExample)
CA (1) CA2831554C (enExample)
ES (1) ES2617989T3 (enExample)
PH (1) PH12013501951A1 (enExample)
SG (3) SG10201602487SA (enExample)
TW (1) TWI642363B (enExample)
WO (1) WO2012133533A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017183595A1 (ja) * 2016-04-20 2017-10-26 株式会社 明治 疲労感の改善用の発酵乳
TWI583388B (zh) * 2016-08-24 2017-05-21 國立體育大學 胚芽乳酸桿菌用於製備改善運動表現及降低肌肉疲勞之益生菌組合物之用途
AU2020289102B2 (en) * 2019-06-03 2025-07-03 Asahi Group Holdings, Ltd. Walking ability improver
JP7593740B2 (ja) * 2020-03-02 2024-12-03 株式会社明治 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物
JP7703165B2 (ja) * 2020-07-27 2025-07-07 独立行政法人国立病院機構 Ｑｏｌ改善剤
TW202442251A (zh) * 2023-04-12 2024-11-01 葡萄王生技股份有限公司 抗疲勞乳酸菌組成物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
DE602004030922D1 (de) * 2003-08-21 2011-02-17 Otsuka Pharma Co Ltd Milchsäurebakterien mit mucosa-immunpotenzierungseffekt
CN101128122B (zh) * 2005-02-23 2011-02-09 大塚制药株式会社 基于茶的发酵饮料和茶饮料
US8182849B2 (en) 2005-02-23 2012-05-22 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
JP5467785B2 (ja) * 2009-03-25 2014-04-09 大塚製薬株式会社 抗鳥インフルエンザウイルス抗体の産生促進剤

Also Published As

Publication number Publication date
AU2012233590A1 (en) 2013-10-10
SG193508A1 (en) 2013-10-30
US20170216379A1 (en) 2017-08-03
SG10201912606QA (en) 2020-02-27
AU2012233590B2 (en) 2017-06-08
CN103458905A (zh) 2013-12-18
KR101878525B1 (ko) 2018-07-13
JPWO2012133533A1 (ja) 2014-07-28
SG10201602487SA (en) 2016-05-30
EP2692349A4 (en) 2014-11-05
EP2692349A1 (en) 2014-02-05
US10369177B2 (en) 2019-08-06
CA2831554A1 (en) 2012-10-04
EP2692349B1 (en) 2016-12-28
JP6061842B2 (ja) 2017-01-18
CA2831554C (en) 2021-08-03
TWI642363B (zh) 2018-12-01
JP6261688B2 (ja) 2018-01-17
TW201244647A (en) 2012-11-16
JP2017019841A (ja) 2017-01-26
US20140017217A1 (en) 2014-01-16
AU2012233590A2 (en) 2014-05-08
KR20140026433A (ko) 2014-03-05
US9623054B2 (en) 2017-04-18
WO2012133533A1 (ja) 2012-10-04
ES2617989T3 (es) 2017-06-20

Similar Documents

Publication Publication Date Title
MD20170035A2 (ro) Compoziţii şi metode de utilizare pentru tratamentul tulburărilor metabolice
PH12017500669A1 (en) Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
GB201103062D0 (en) Method
MX355543B (es) Macrociclos peptidomiméticos.
MD20170020A2 (ro) Compoziţii şi metode utilizate pentru tratamentul tulburărilor metabolice
MX381456B (es) Regulador de ph de transduccion.
MX2017010150A (es) Bacterias probioticas recombinantes.
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
PH12014501844B1 (en) Peptidomimetic macrocycles
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
PH12014500767A1 (en) Compositions for the treatment of dry eye
MX354267B (es) Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos.
NZ708727A (en) Conjugate compounds
SG195114A1 (en) Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
PH12013501951A1 (en) Agent for improving or maintaining qol
MX365403B (es) Peptidos y metodos para usarlos.
PH12016501777A1 (en) Novel lactobacillus paracasei strain
PH12014502680A1 (en) Polysaccharide compositions and methods of use
MX344590B (es) Inhibidores de f1f0-atpasas de tipo pirazolilguanidina y sus usos terapéuticos.
SG10201804952QA (en) Glucosylceramide synthase inhibitors
IN2014DN00254A (enExample)
MX362854B (es) Siarn y su uso en los metodos y composiciones para el tratamiento y/o prevencion de enfermedades de los ojos.
IN2012DN01846A (enExample)
MX2013012603A (es) Vancomicina liposomal para el tratamiento de infecciones por estafilococo aureus resistente a la meticilina (sarm).
TH156777A (th) เอเจนต์เพื่อปรับปรุงหรือบำรุงรักษา qol